Abstract 15626: Novel Function Annotation Tool Revealed Obesity-Induced Inflammation is Exacerbated by miR-150 Regulated B Cell Receptor Signaling
03 medical and health sciences
0302 clinical medicine
DOI:
10.1161/circ.148.suppl_1.15626
Publication Date:
2023-12-19T08:08:02Z
AUTHORS (7)
ABSTRACT
B cells exacerbate obesity-induced metabolic dysfunction and become the second most abundant immune lineage in obese adipose tissue. However, high-resolution strategies to interrogate cellular dynamics driving cell responses under chronic obesity stress are lacking, stifling innovative cell-targeted therapies against health risk. Our previous work established potent role of miR-150 tissue B cells’ (ATB) pro-inflammatory obesity. This project aims elucidate mechanism of miR-150 regulated ATB actions that bolster inflammation. Method: We employed single-cell techniques decipher obesity-perturbed signaling networks cell-specific gain/loss function mouse models  vivo and  ex . utilized our novel annotation tool, B-RAY, to quantify B cytokine production, antibody secretion, antigen presentation from RNA-Seq. These strengths permitted several key findings: Result: A) overexpression mature alone improved systemic glucose tolerance obesity, despite similar body adiposity. In line, knock-out worsened tolerance. B) tissue, were skewed towards higher production away secretion compared lean Importantly, ATBs displayed increased activity direct targets, Myb, Etf1, Elk1, reduced expression miR-150. C) enriched receptor (BCR) downstream cascades. exhibited BCR-mediated Syk phosphorylation calcium influx, while yielded enhanced responses. Conclusion: results support hypothesis regulation limits inflammation tissue via modulating BCR prevent excessive presentation. Future will investigate activation in miR-150 mice across time diet-induced Collectively, this an important immunoregulatory network bolstering health risk.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....